Synaptics(DE:SJN)
€105.000.00 (0.00%)
DE:SJN
Synaptics financials statements
€105.00
At close:0.00 (0.00%)
Synaptics (SJN) Ratios
2 Followers
Synaptics Ratios
DE:SJN's free cash flow for Q1 2027 was $-18.60M. For the 2027 fiscal year, DE:SJN's free cash flow was decreased by $-3.10M and operating cash flow was $-15.50M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 2.78 | 4.19 | 4.89 | 3.03 |
| Quick Ratio | 0.90 | 2.26 | 3.78 | 4.36 | 2.66 |
| Cash Ratio | 0.63 | 1.45 | 3.03 | 3.56 | 1.78 |
| Solvency Ratio | -0.29 | 0.08 | 0.17 | 0.17 | 0.25 |
| Operating Cash Flow Ratio | 0.21 | 0.52 | 0.49 | 1.27 | 1.00 |
| Short-Term Operating Cash Flow Coverage | 0.34 | 0.00 | 22.65 | 55.25 | 77.12 |
| Net Current Asset Value | $ -385.50M | $ -437.60M | $ -195.90M | $ -96.00M | $ -188.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.34 | 0.36 | 0.39 | 0.36 |
| Debt-to-Equity Ratio | 0.90 | 0.63 | 0.70 | 0.83 | 0.82 |
| Debt-to-Capital Ratio | 0.47 | 0.39 | 0.41 | 0.45 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.37 | 0.40 | 0.44 | 0.44 |
| Financial Leverage Ratio | 2.26 | 1.85 | 1.93 | 2.10 | 2.26 |
| Debt Service Coverage Ratio | -0.69 | 3.39 | 4.21 | 4.67 | 11.98 |
| Interest Coverage Ratio | -2.87 | -2.36 | -1.56 | 2.78 | 11.60 |
| Debt to Market Cap | 0.18 | 0.33 | 0.29 | 0.29 | 0.21 |
| Interest Debt Per Share | 22.13 | 23.41 | 27.74 | 27.40 | 27.46 |
| Net Debt to EBITDA | 4.21 | 7.04 | 3.68 | 0.31 | 0.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.72% | 44.72% | 45.84% | 52.83% | 54.21% |
| EBIT Margin | -4.68% | -6.86% | -6.18% | 13.39% | 20.16% |
| EBITDA Margin | 7.83% | 6.46% | 5.20% | 25.04% | 28.64% |
| Operating Profit Margin | -5.60% | -8.76% | -10.59% | 11.39% | 20.14% |
| Pretax Profit Margin | -6.63% | -10.57% | -12.99% | 9.30% | 18.51% |
| Net Profit Margin | -41.00% | -4.45% | 13.09% | 5.43% | 14.80% |
| Continuous Operations Profit Margin | -41.00% | -4.45% | 13.09% | 5.43% | 14.80% |
| Net Income Per EBT | 618.14% | 42.11% | -100.80% | 58.41% | 79.94% |
| EBT Per EBIT | 118.33% | 120.62% | 122.64% | 81.66% | 91.92% |
| Return on Assets (ROA) | -23.35% | -1.85% | 4.45% | 2.82% | 9.01% |
| Return on Equity (ROE) | -52.80% | -3.43% | 8.56% | 5.92% | 20.33% |
| Return on Capital Employed (ROCE) | -4.79% | -4.07% | -3.99% | 6.56% | 14.63% |
| Return on Invested Capital (ROIC) | -3.65% | -1.68% | 3.99% | 3.81% | 11.63% |
| Return on Tangible Assets | -47.11% | -3.65% | 7.30% | 4.92% | 15.50% |
| Earnings Yield | -10.43% | -1.88% | 3.72% | 2.18% | 5.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.30 | 8.24 | 6.68 | 8.20 | 5.38 |
| Payables Turnover | 8.01 | 6.03 | 5.94 | 13.96 | 5.62 |
| Inventory Turnover | 4.23 | 4.26 | 4.56 | 4.66 | 4.69 |
| Fixed Asset Turnover | 13.78 | 9.16 | 7.84 | 11.74 | 14.02 |
| Asset Turnover | 0.57 | 0.42 | 0.34 | 0.52 | 0.61 |
| Working Capital Turnover Ratio | 4.23 | 1.57 | 1.01 | 1.39 | 2.61 |
| Cash Conversion Cycle | 90.70 | 69.47 | 73.25 | 96.69 | 80.61 |
| Days of Sales Outstanding | 50.00 | 44.27 | 54.63 | 44.50 | 67.83 |
| Days of Inventory Outstanding | 86.26 | 85.73 | 80.08 | 78.34 | 77.76 |
| Days of Payables Outstanding | 45.56 | 60.54 | 61.47 | 26.15 | 64.97 |
| Operating Cycle | 136.26 | 130.00 | 134.71 | 122.84 | 145.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.84 | 3.61 | 3.47 | 8.37 | 11.86 |
| Free Cash Flow Per Share | 2.61 | 2.70 | -0.81 | 7.51 | 10.30 |
| Dividend Paid and CapEx Coverage Ratio | 3.11 | 3.97 | 0.81 | 9.69 | 7.57 |
| Capital Expenditure Coverage Ratio | 3.11 | 3.97 | 0.81 | 9.69 | 7.57 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.16 | 0.13 | 0.32 | 0.44 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.13 | 0.14 | 0.24 | 0.27 |
| Free Cash Flow Yield | 2.15% | 4.17% | -0.94% | 8.79% | 8.72% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.59 | -53.10 | 26.87 | 45.94 | 17.88 |
| Price-to-Sales (P/S) Ratio | 3.93 | 2.37 | 3.52 | 2.50 | 2.65 |
| Price-to-Book (P/B) Ratio | 5.06 | 1.83 | 2.30 | 2.72 | 3.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 46.42 | 23.97 | -106.45 | 11.37 | 11.46 |
| Price-to-Operating Cash Flow Ratio | 31.51 | 17.93 | 24.83 | 10.20 | 9.95 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.38 | 0.37 | -0.64 | 0.09 |
| Enterprise Value Multiple | 54.39 | 43.73 | 71.30 | 10.27 | 9.68 |
| Enterprise Value | 5.10B | 3.03B | 3.56B | 3.49B | 4.82B |
| EV to EBITDA | 54.39 | 43.73 | 71.30 | 10.27 | 9.68 |
| EV to Sales | 4.26 | 2.82 | 3.71 | 2.57 | 2.77 |
| EV to Free Cash Flow | 50.31 | 28.57 | -112.23 | 11.72 | 12.00 |
| EV to Operating Cash Flow | 34.15 | 21.37 | 26.18 | 10.52 | 10.42 |
| Tangible Book Value Per Share | -3.36 | 3.08 | 9.23 | 3.24 | 1.79 |
| Shareholders’ Equity Per Share | 23.89 | 35.49 | 37.42 | 31.40 | 32.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -5.18 | 0.58 | 2.01 | 0.42 | 0.20 |
| Revenue Per Share | 30.78 | 27.34 | 24.47 | 34.22 | 44.61 |
| Net Income Per Share | -12.62 | -1.22 | 3.20 | 1.86 | 6.60 |
| Tax Burden | 6.18 | 0.42 | -1.01 | 0.58 | 0.80 |
| Interest Burden | 1.42 | 1.54 | 2.10 | 0.69 | 0.92 |
| Research & Development to Revenue | 0.32 | 0.32 | 0.35 | 0.26 | 0.21 |
| SG&A to Revenue | 0.17 | 0.17 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.12 | 0.10 | 0.12 | 0.09 | 0.06 |
| Income Quality | -0.30 | -2.97 | 1.08 | 4.50 | 1.80 |
Currency in USD

